Novel Gene-Therapy Approach for Glaucoma

Principal Investigator

Co-Principal Investigator

Summary

The project aims to develop and test resources for Schlemm’s canal specific targeting and expression of genes for gene therapy. Successful development of this targeted therapy will help control eye pressure more effectively and provide better treatment options for glaucoma patients.

First published on: November 16, 2021

Last modified on: December 07, 2022